Héctor Bueno is an expert in Cardiology at Hospital Universitario 12 De Octubre (Spain). As of October 2026, ScienceLeadR ranks Héctor Bueno in the top 1% of experts worldwide for Myocardial Ischemia and Heart Failure, and in the top 1% of experts in Spain for Arteriosclerosis. Héctor Bueno has authored 663 publications, the most recent in 2026, and is an investigator in 19 clinical trials. SLR score: 2,299 (community average: 125). How the SLR is computed.

LeadR Profile

2 299 ScienceLeadR Reputation 2299
Network Map

Cardiology

Subspecialties: Public Health - Geriatrics - Internal Medicine

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 1994 - 2026

Source: PubMed

Hospital Universitario 12 De Octubre

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 663

Citations

Citations: 172 056 1st author: 46 Last author: 119 Unique author: 13


Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Milvexian with Antiplatelet Therapy after Acute Coronary Syndrome Event.
PMID 42670965 — safety, hemorrhage, ischemic stroke, stroke, myocardial infarction, acute coronary syndrome, therapeutics
N Engl J Med Top journal20264
Closing the implementation gap: the Joint Action on Cardiovascular Diseases and Diabetes (JACARDI) as a proof of-concept for Europe's Safe Hearts Plan.
PMID 42375318 — diabetes mellitus, heart, cardiovascular diseases, public health
Int J Public Health20260
Covidence, Rayyan, EPPI Centre, Distiller SR, RevMan.
PMID 41769352 — libraries, medical
J Med Libr Assoc20261
Rationale and Design of the Pre-MYO Project: A Precision-Medicine Platform for Myocarditis Diagnosis and Management.
PMID 41711201 — heart failure, biomarkers, myocarditis, precision medicine, diagnosis
ESC Heart Fail20260
Strengthening non-communicable diseases monitoring systems in Europe through a multistakeholder collaborative approach: a key priority for advancing data-driven policymaking.
PMID 41488490 — noncommunicable diseases, communicable diseases
Lancet Reg Health Eur20250

Clinical Studies 19

Sources: ClinicalTrials, EU CTIS

Synthesis

Principal Investigator: 2

By phase:

N/A 9
Phase 3 4
Phase 2 3
Phase 4 3

By status:

Completed 15
Unknown 2
Active not recruiting 1
Terminated 1

By type:

Interventional 14
Observational 5

By Monocentric/Multicentric:

monocentric 4
multicentric2to4 0
multicentric5to9 0
multicentricup10 15

Main Topics

Cohort/Consortium Investigators 2

LeadR Networks

Main global connection map